Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Director/PDMR Shareholding

May 25, 2021
RNS Number : 7052Z Renalytix AI PLC 25 May 2021   Renalytix AI plc     ("Renalytix" or the "Company")   Director/PDMR Dealing   New York , 25 May 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by James McCullough , the Company's Chief Executive Officer, of 10,462

Director/PDMR Dealing

May 21, 2021
RNS Number : 4140Z Renalytix AI PLC 21 May 2021   Renalytix AI plc     ("Renalytix" or the "Company")    Director/PDMR Dealing   New York , 21 May 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by James McCullough , the Company's Chief Executive Officer, of 54,538

Partnership

May 19, 2021
RNS Number : 1113Z Renalytix AI PLC 19 May 2021   Renalytix AI plc   (" RenalytixAI " or the " Company ")     ATRIUM HEALTH, WAKE FOREST BAPTIST HEALTH, WAKE FOREST SCHOOL OF MEDICINE  AND RENALYTIX PARTNER TO ADVANCE KIDNEY HEALTH   Partnership marks a long-term commitment to reducing impact of

Second Price Monitoring Extn

April 22, 2021
RNS Number : 3487W Renalytix AI PLC 22 April 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

Price Monitoring Extension

April 22, 2021
RNS Number : 3466W Renalytix AI PLC 22 April 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

Second Price Monitoring Extn

April 22, 2021
RNS Number : 3204W Renalytix AI PLC 22 April 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

Price Monitoring Extension

April 22, 2021
RNS Number : 3183W Renalytix AI PLC 22 April 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

10-year US Government contract award

April 22, 2021
RNS Number : 2366W Renalytix AI PLC 22 April 2021     Renalytix AI plc   (" RenalytixAI " or the " Company ")     U.S. General Services Administration Grants 10-Year Governmentwide Contract for RenalytixAI KidneyIntelX Testing   KidneyIntelX Testing Services Available to 140 U.S.

Positive clinical outcome data for KidneyIntelX

April 20, 2021
RNS Number : 9600V Renalytix AI PLC 20 April 2021     Renalytix AI plc   (" RenalytixAI " or the " Company ")     KidneyIntelX Demonstrates Performance and Informs Treatment Decisions in Multinational CANagliflozin CardioVAScular Assessment Study (CANVAS)   Data from 1,325 CANVAS Participants with

Director/PDMR Shareholding

April 19, 2021
RNS Number : 8100V Renalytix AI PLC 19 April 2021     Renalytix AI plc   Director/PDMR Shareholding   New York , 19 April 2021 - Renalytix AI plc   (LSE : RENX) (NASDAQ: RNLX) ("RenalytixAI" or the "Company"), an artificial intelligence -enabled in vitro   diagnostics company, focused on optimizing
Displaying 81 - 90 of 209